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Fragment A of diphtheria toxin and Pseudomonas toxin A intoxicate cells by ADP-ribosylating the 
diphthamide residue of elongation factor-2 (EF-2) resulting in an inhibition of protein synthesis [l-3]. A 
cellular enzyme from polyoma virus transformed baby hamster kidney (pyBHK) cells ADP-ribosylates 
EF-2 in an identical manner [4]. Here we describe a similar cellular enzyme from beef liver which transfers 
[adenosine-r4C]ADP-ribose from NAD to EF-2. The 14C-label can be removed from the EF-2 by snake 
venom phosphodiesterase as a soluble product which comigrates with AMP on TLC plates, indicating the 
14C-label is present on EF-2 as monomeric units of ADP-ribose. Furthermore, the forward transferase 
reaction catalyzed by the beef liver ADP-ribosyltransferase is reversible by excess diphtheria toxin 
fragment A, with the formation of i4C-labeled NAD, indicating that both transferases ADP-ribosylate the 
same site on the diphthamide residue of EF-2. Thus, beef liver and pyBHK mono(ADP- 
ribosyl)transferases both modify the diphthamide residue of EF-2, in a manner identical to diphtheria 
toxin fragment A and Pseudomonas toxin A. These results suggest the cellular enzyme is probably 
ubiquitous among eukaryotic cells. 
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1. INTRODUCTION 
We have recently described the first cellular 
mono(ADP-ribosyl)transferase from polyoma 
virus transformed baby hamster kidney (pyBHK) 
cells which ADP-ribosylates eukaryotic EF-2 in a 
manner identical to fragment A of diphtheria toxin 
and Pseudomonas toxin A [4]. We suggested that 
the cellular enzyme was part of an endogenous en- 
zyme system of eukaryotic cells which is taken over 
by these two microbial toxins during the process of 
intoxication. Since these bacterial toxins affect a 
number of different types of cells [5-81, the en- 
dogenous cellular ADP-ribosyltransferase system 
should also have a broad distribution. The initial 
isolation of the cellular ADP-ribosyltransferase 
was from pyBHK cells which are both virus in- 
fected and transformed and consequently might 
contain a unique enzyme not found in normal 
tissue. In this report, however, we describe an 
ADP-ribosyltransferase which has now been 
isolated from normal beef liver. The finding of this 
enzyme in two different tissues from two different 
species of animals suggests it is probably ubi- 
quitous among eukaryotic cells. 
2. MATERIALS AND METHODS 
2.1. Partial purification of beef liver elongation 
factor-2 
A fresh 21 lb beef liver was obtained from a 
local slaughterhouse, divided into 100 g portions 
and frozen at -70°C. Elongation factor-2 (EF-2) 
from beef liver was partially purified according to 
a procedure for purification of EF-2 from hamster 
tumors [9]. Briefly, rapidly thawed liver was 
homogenized in a sucrose containing buffer at 5°C 
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in a Waring blender. A postmitochondrial fraction 
was selected by centrifugation and precipitated 
with ammonium sulfate added to 80% saturation. 
The precipitate was dissolved in buffer A [4] and 
sequentially chromatographed on DEAE-cellulose, 
Sephadex DEAE ASO, Sephacryl S-200 and 
phosphocellulose. Chromatographic fractions rich 
in EF-2 were assayed by the specific transfer of 
[~~e~o~~~e-14C]ADP-ribose from NAD (534 mCi/ 
mM) to EF-2 by diphtheria toxin fragment A as in 
[lo]. The preparations of partially purified EF-2 
were analyzed by SDS-polyacrylamide gel electro- 
phoresis [9], 
2.2. ~~~-~~bosyi~i~o~ of preparations of beef 
liver EF-2 
The partially purified liver EF-2 preparations 
also served as the source of the cellular ADP- 
ribosyltransferase. Diphtheria toxin fragment A 
was purified as in [ 111. ADP-ribosyltransferase ac- 
tivity was measured by the incorporation of 
radioactivity from [a&nosine(U)-‘4C]NAD into 
trichloroacetic acid precipitable material in the 
presence of EF-2 as in [4,9]. The reaction mixture 
contained 2.5 mM Tris-HCl (pH 8.0), 1 mM 
dithiothreitol, 6.33 FM [~~e~o~~~e(U)-14C]NAD 
(534 mCi/mM) (New England Nuclear Co.), and 
EF-2 at 50 pg/ml with or without added fragment 
A at 0.5 pg/ml. After intervals of incubation at 
22”C, 10 ~1 samples were trichloroacetic acid pre- 
cipitated and the radioactivity was measured [4,9]. 
2.3. Snake venom phosphodiesterase digestion of 
ADP-ribosylated EF-2 
Digestion with snake venom phosphodiesterase 
(Worthington Biochemical) was used to distinguish 
between mono- or poly-ADP-ribosylation of EF-2 
by the endogenous transferase as described 141. 
EF-2 was ADP-ribosylated by the cellular ADP- 
ribosyltransferase in the presence of 14C-labeled 
NAD and then dialyzed to remove NAD. Then 
25 ~1 of snake venom phosphodiesterase was add- 
ed and incubated 15 min at 37°C. The digestion 
products were chromatographed on thin-layer 
polyethyleneimine cellulose plates (I-T. Baker) 
with 0.3 M lithium chloride, dried and exposed to 
X-ray film (Kodak XPP-5) to locate the 14C- 
labeled products relative to the UV light adsorbing 
AMP, adenosine, ADP-ribose and NAD markers 
(Sigma). 
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2.4. Reversal of the ADP-ribosylation reaction 
Reversal reactions were done by incubating the 
product of the forward reaction ([*4C]adenosine 
labeled EF-2) at pH 6.6 with an excess of fragment 
A (10 pg/ml) and 2 mM nicotinamide at 22°C as 
previously described [4], The radioactive products 
were analyzed by thin-layer polyethyleneimine 
cellulose chromatography as described above. 
3. RESULTS AND DISCUSSION 
3.1. Transfer of [“Cjadenosine from NAD to 
EF-2 by the endogenous transferase 
Beef liver EF-2 was partially purified by sequen- 
tia1 column chromatography on DEAE-cellulose, 
Sephadex DEAE A50, Sephacryl S-200 and 
phosphocellulose as in [9]. The partially purified 
beef liver EF-2 preparation consisted of a major 
band of 93-kDa protein and trace bands of lower 
molecular mass proteins when reduced and ana- 
lyzed by SDS-polyacrylamide gel ele~trophoresis 
(fig.lA). The major band represented >90% of 
the stainable protein on the gels. Incubation of the 
partially purified EF-2 preparation which con- 
tained the endogenous transferase with [adeno- 
sine-‘4C]NAD resulted in the transfer of 14C-label 
to an acid precipitable form. EF-2 could also be 
labeled by addition of diphtheria toxin fragment 
A. Since the fragment A catalyzed reaction reaches 
saturation in < 5 min and the endogenous transfer- 
ase catalyzed reaction requires > 160 min of incu- 
bation, the “C-labeled acceptor could be preferen- 
tially labeled by either enzyme [4]. Moreover, the 
transfer of label to the acceptor by sequential addi- 
tion of the two enzymes is not additive (unpub- 
lished data). SDS-polyacrylamide gel analysis of 
the products labeled by the cellular transferase or 
fragment A indicated that the label was transferred 
to a 93-kDa protein which comigrates with EF-2 
[4,9], as shown in fig.lB. 
3.2. Snake venom phosphodiesterase digestion of 
“C-labeled EF-2 
To determine if the EF-2 modified by the beef 
liver ADP-ribosyltransferase contains monomers 
or polymers of ADP-ribose, we synthesized the 
labeled product formed in the presence of the 
endogenous cellular transferase, [adeno- 
sine-‘4C]NAD and EF-2 and then treated the la- 
beled product with snake venom phosphodiester- 
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Fig. 1. SDS-polyacrylamide gel analysis of partially 
purified beef liver EF-2 and of the EF-2 preparation 
labeled with [r4C]adenosine by diphtheria toxin 
fragment A and the endogenous transferase. EF-2 was 
partially purified from homogenates of beef liver as 
described in section 2. Gels containing 8.5070 acrylamide 
and 0.1% sodium dodecyl sulfate (SDS) were prepared 
as in [9]. Following electrophoresis the protein bands 
were stained with Coomassie brilliant blue stain as 
shown in (A). Lanes from right to left: beef liver EF-2 
preparation incubated with [ff~e~o~~~e-14C]NA~ for 
160 min; and beef liver EF-2 incubated with 
[udenosine-t4C]NAD and 0.05 pg of diphtheria toxin 
fragment A for 160 min. The numbers represent M, x 
10m3 of the protein standards. Following electrophor- 
esis, the dried gel was exposed to X-ray film to locate 
proteins labeled with [14C]adenosine by the two transfer- 
ases as hown in (B). Lanes from right to left: proteins 
labeled with [r4C]adenosine by the endogenous transfer- 
ase in beef liver EF-2 preparations and proteins labeled 
with [‘4C]adenosine by fragment A. The major stained 
and 14C-labeled protein comigrates with the 93-kDa 
phosphorylase b molecular mass marker protein. 
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ase (SVP). EF-2 modified by fragment A was used 
in an accompanying reaction mixture as a positive 
control. In both reactions the soluble products 
resulting from digestion with snake venom phos- 
phodiesterase cochromatographed with each other 
and with the UV light absorbing AMP marker 
(fig.2). Some tailing of 14C-labeled AMP in the 
chromatogram was observed due to the salt effect 
of the MgClz component in the SVP catalyzed 
Fig.2. Thin-layer chromatography of the snake venom 
phosphodiesterase digestion products from beef liver 
EF-2 labeled by fragment A or the beef liver endogenous 
transferase with [udenosine-t4C]NAD. The beef liver 
EF-2 was labeled by fragment A or by the endogenous 
transferase in our standard reaction mixture, the 
products were digested with snake venom phosphodies- 
terase (SVP) and chromatographed on thin-layer plates 
as described in section 2. The radioactive products are 
visualized by autoradiography. The lanes from left to 
right represent he soluble products from EF-2 labeled in 
the presence of [adenosine-14C]NAD by: (a) fragment A; 
(b) endogenous transferase; (c) fragment A followed by 
5 min digestion with SVP; (d) fragment A followed by 
15 min digestion with SVP; (e) endogenous transferase 
followed by 5 min digestion with SVP; and (f) endo- 
genous transferase followed by 15 min digestion with 
SVP. ADPR, AMP, Aden. and NAD refer to the 
chromatographic positions of the UV-light absorbing 
standards of ADP-ribose, AMP, adenosine and NAD 
which have the Ri values of 0.65, 0.53, 0.40, and 0.25, 
respectively. 
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reaction. The same tailing effect of the AMP 
standard was observed when the standards were 
treated and chromatographed under the same con- 
ditions as the unknowns. The effect was identical 
in all reactions and does not obscure the region of 
the chromatogram where the ADP-ribose standard 
migrates. Since AMP is the product of snake 
venom phosphodiesterase action on mono ADP- 
ribosylated proteins, we conclude that ADP-ribose 
is present on the acceptor in EF-2 as monomeric 
units. 
3.3. Reversal of the ADP-ribosylation reaction 
The ADP-ribosylation of EF-2 by mono(ADP- 
ribosyl)transferases is reversible [4,12,13]. Since 
these ADP-ribosyltransferases ynthesize identical 
products, it is possible to drive the forward reac- 
tion with one type of ADP-ribosyltransferase and 
then catalyze the reversal reaction with a second 
type of transferase (4,12,13]. A preparation of 
[ 14C]adenosine labeled beef liver EF-2 containing a 
small amount of beef liver ADP-ribosyltransferase 
(used in the forward reaction) was incubated in the 
absence or presence of excess fragment A and 
nicotinamide to reverse the reaction. The 14C- 
labeled product generated in this reversal reaction 
was analyzed by thin-layer chromatography. The 
14C-labeled soluble product found in the reverse 
reaction mixtures cochromatographed with the 
marker NAD (fig.3), indicating that the beef liver 
enzyme ADP-ribosylates the diphthamide residue 
of EF-2 in a manner identical to that of fragment 
A of diphtheria toxin, Pseudomonas toxin A and 
pyBHK cellular mono(ADP-ribosyl)transferase. 
The mono(ADP-ribosyl)transferases from beef 
liver and from pyBHK cells are found in EF-2 
preparations when the EF-2 is partially purified as 
in [4,9]. Although the enzyme is found in our EF-2 
preparations the activity can be separated from 
pyBHK EF-2 using an immunoadsorbant column 
containing polyvalent antibody prepared by im- 
munizing Balb/c mice with an EF-2 preparation 
having the cellular transferase activity (unpub- 
lished data). The cellular ADP-ribosyltransferase 
binds to the immunoadsorbant column and can be 
eluted in an enzymatically active form, while 
pyBHK EF-2 does not bind to the resin. Thus, the 
transferase activity is distinct from EF-2 and either 
co-purifies with EF-2 or is a minor contaminant in 
our EF-2 preparations. 
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Beef liver serves as a convenient source for the 
cellular ADP-ribosyltransferase but we have found 
that the yield of beef liver EF-2 and its ADP- 
ribosyltransferase to be much lower (approximate- 
ly 1120) than the yield of pyBHK EF-2 and its 
copurifying ADP-ribosyltransferase enzyme. We 
have also found that the activity of the beef liver 
ADP-ribosyltranferase is much less stable than the 
enzyme isolated from pyBHK cells. Enzyme activi- 
ty is rapidly lost when frozen at - 7O”C, suggesting 
the beef liver ADP-ribosyltransfer~e may be inac- 
Fig.3. Thin-layer chromatography of the products 
formed by the reversal reaction. Beef liver EF-2 was 
radioactively labeled by diphtheria toxin fragment A 
(0.5 pg/ml) or the endogenous ADP-ribosyltransferase 
from the beef liver EF-2 preparation as shown in fig. 1B. 
After exhaustive dialysis to remove NAD, the labeled 
proteins were incubated in Tris-HCl buffer (pH 6.6). 
For the reverse reaction the “C-iabeled EF-2 
prep~ations were incubated with an excess of fragment 
A (10 pg/ml) and 2 mM nicotinamide. The products of 
the reversal were analyzed by thin-layer chromatography 
using the same chromatographic system shown in fig.2. 
Untreated ADP-ribosylated EF-2 was spotted at the 
origin of one lane as a contro1. Radioactive compounds 
were visualized by autoradiography. Lanes from left to 
right: untreated ADP-ribosylated EF-2; reversal product 
from EF-2 labeled in the presence of [adenosine-r4C]- 
NAD by fragment A; and reversal product of EF-2 
labeled by the beef liver endogenous transferase. The 
14C-labeled soluble product of the reversal cochroma- 
tographed with the NAD standard. 
tivated by the process of freezing. We normally 
store the beef liver EF-2 preparations in ice and use 
them as rapidly as possible. In contrast, the ADP- 
ribosyItransferase from pyBHK cells is stable when 
stored at - 70°C and is more suitable for long term 
studies. 
Similar mono(ADP-ribosyl)transferases have 
now been isolated from two different tissues of dif- 
ferent species of animals. Since the unique 
diphth~ide residue of EF-2 has been stringentiy 
conserved in eukaryotic cells from yeast to man 
[5,6,14] it seems likely that the mono(ADP- 
ribosyl)transferase which ADP-ribosylates this ac- 
ceptor site will also be common to these eukaryotic 
cells. The stringent conservation of the 
diphthamide residue and, apparently, the cellular 
mono(ADP-ribosyl)transfer~e suggests an essen- 
tial physiological function, perhaps ‘fine tuning’ 
of protein synthesis at the level of functional EF-2. 
A model for the potential relationship of microbial 
toxins and cellular ADP-ribosyltransferases has 
recently been presented together with a potential 
explanation for the selective toxicity of the 
microbial ADP-ribosyltransferase over its cellular 
counterpart [15]. It will now be important to 
demonstrate the active form of this enzyme in vivo 
and to determine under what conditions that pro- 
posed ‘fine tuning’ mechanism is operational. 
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